Home > BRISA > Search result
COVID-19

In this section you will find the HTA reports produced by RedETSA members in response to the COVID-19 pandemic. For additional resources, please visit PAHO’s website.


Limitation of Liability

The information, products, services, tools and/or opinions shared and expressed on the platform are the sole responsibility of the institutions that produce them, and do not necesarily represent the views of PAHO/WHO.

PAHO/WHO and its Specialized Center BIREME make no warranties nor guarantees the accuracy or truthfulness of the information, products, services and/or tools provided. Users must use these products, services and/or tools at their own risk. In no case will PAHO/WHO and its Specialized Center BIREME be liable for damages, even if they may have been warned and/or prevented.

Terms and conditions of use

Results: 2

Análisis de costo-efectividad de ondansetrón, alizaprida, domperidona, granisetrón, aprepitant, propofol, dexametasona, dimenhidrinato, metoclopramida y haloperidol para la profilaxis y/o tratamiento de pacientes con náusea y vómito en Colombia

Instituto de Evaluación Tecnológica en Salud.
INTRODUCCIÓN: El análisis de costo-efectividad de ondansetrón, alizaprida, domperidona, granisetrón, aprepitant, propofol, dexametasona, dimenhidrinato, metoclopramida y haloperidol para la profilaxis y/o tratamiento de pacientes con náusea y vómito en Colombia, se desarrolla en el marco del mecani...
Nausea/drug therapy, Vomiting/drug therapy, Ondansetron/therapeutic use, Domperidone/therapeutic use, Granisetron/therapeutic use, Aprepitant/therapeutic use, Propofol/therapeutic use, Dexamethasone/therapeutic use, Dimenhydrinate/therapeutic use, Metoclopramide/therapeutic use, Haloperidol/therapeutic use, Efficacy, Health Evaluation/economics, Colombia
Fulltext

Informe diário de evidências COVID-19: busca realizada em 29 de julho de 2020

Brasil. Ministério da Saúde. Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde.
O Informe Diário de Evidências é uma produção do Ministério da Saúde que tem como objetivo acompanhar diariamente as publicações científicas sobre tratamento farmacológico e vacinas para a COVID-19. Dessa forma, são realizadas buscas estruturadas em bases de dados biomédicas, referentes ao d...
Coronavirus Infections/drug therapy, Pneumonia, Viral/drug therapy, Betacoronavirus/drug effects, Influenza Vaccines/therapeutic use, Chloroquine/therapeutic use, Hydroxychloroquine/therapeutic use, Anti-Inflammatory Agents, Non-Steroidal/therapeutic use, Resveratrol/therapeutic use, Copper/therapeutic use, Interferon alpha-2/therapeutic use, Midazolam/therapeutic use, Ketamine/therapeutic use, Fentanyl/therapeutic use, Propofol/therapeutic use, Immunoglobulins/therapeutic use, Lopinavir/therapeutic use, Ritonavir/therapeutic use, Methylprednisolone/therapeutic use, Azithromycin/therapeutic use, Enoxaparin/therapeutic use, Cohort Studies, Cross-Sectional Studies, Technology Assessment, Biomedical
Fulltext